Citius Pharmaceuticals, Inc.

CTXR

$0.60

-0.35%

N/A-$0.00

Salud

Biotecnología

NASDAQ

Negociación activa

Citius Pharmaceuticals, Inc. opera como una empresa farmacéutica especializada centrada en el desarrollo y la introducción en el mercado de productos de ...

Transacciones de insiders de CTXR

Compras (A)

Since Nov 7, 2024

Ventas (D)

Since Nov 7, 2024

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Resumen de trading de insiders

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio
Aug 8, 2025	Mazur Leonard L	director, officer: Chief Executive Officer	Warrant to Purchase Common Stock	A	125,490	$28.75
Aug 8, 2025	Mazur Leonard L	director, officer: Chief Executive Officer	Warrant to Purchase Common Stock	A	89,388	$19.25
Aug 8, 2025	Mazur Leonard L	director, officer: Chief Executive Officer	Warrant to Purchase Common Stock	D	125,490	$28.75
Aug 8, 2025	Mazur Leonard L	director, officer: Chief Executive Officer	Warrant to Purchase Common Stock	D	89,388	$19.25
Aug 8, 2025	HOLUBIAK MYRON Z	director, officer: Vice Chairman	Warrant to Purchase Common Stock	A	31,373	$28.75

Resumen de trading de insiders

Compras (A)

Ventas (D)

Acciones compradas totales

518,595

Acciones vendidas totales

268,595

Actividad mensual de insiders

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Por cargo - Acciones

Eje X: acciones, ordenado por acciones totales desc.

Por cargo - Conteos

Eje X: conteos, ordenado por conteos A+D desc.

Personas clave: actividad de compra/venta y precio

Mazur Leonard L

director, officer: Chief Executive Officer • 4 transacciones

HOLUBIAK MYRON Z

director, officer: Vice Chairman • 4 transacciones

Webb Carol

director • 1 transacciones

Smith Robert Joseph

director • 1 transacciones

Tabla de transacciones

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio	Valor
Aug 8, 2025	Mazur Leonard L	director, officer: Chief Executive Officer	Warrant to Purchase Common Stock	A	125,490	$28.75	$3,607,837.50
Aug 8, 2025	Mazur Leonard L	director, officer: Chief Executive Officer	Warrant to Purchase Common Stock	A	89,388	$19.25	$1,720,719.00
Aug 8, 2025	Mazur Leonard L	director, officer: Chief Executive Officer	Warrant to Purchase Common Stock	D	125,490	$28.75	$3,607,837.50
Aug 8, 2025	Mazur Leonard L	director, officer: Chief Executive Officer	Warrant to Purchase Common Stock	D	89,388	$19.25	$1,720,719.00
Aug 8, 2025	HOLUBIAK MYRON Z	director, officer: Vice Chairman	Warrant to Purchase Common Stock	A	31,373	$28.75	$901,973.75
Aug 8, 2025	HOLUBIAK MYRON Z	director, officer: Vice Chairman	Warrant to Purchase Common Stock	A	22,344	$19.25	$430,122.00
Aug 8, 2025	HOLUBIAK MYRON Z	director, officer: Vice Chairman	Warrant to Purchase Common Stock	D	22,344	$19.25	$430,122.00
Aug 8, 2025	HOLUBIAK MYRON Z	director, officer: Vice Chairman	Warrant to Purchase Common Stock	D	31,373	$28.75	$901,973.75
Nov 7, 2024	Webb Carol	director	Stock Option (Right to Purchase Common Stock)	A	125,000	$0.38	$47,500.00
Nov 7, 2024	Smith Robert Joseph	director	Stock Option (Right to Purchase Common Stock)	A	125,000	$0.38	$47,500.00

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal